Market Overview:
The global bone and joint health ingredients market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 3.6 Billion |
Market Forecast in 2032
|
US$ 5.9 Billion |
Market Growth Rate 2024-2032 |
5.4% |
Bone and joint health ingredients refer to the herbal and natural extracts and compounds that are rich in essential nutrients and added to food and beverages to promote bone growth. The ingredients are primarily obtained from plant and animal-based sources, including turmeric, Boswellia, tart cherries, eggshell membranes and chondroitin. They have a high content of amino acids, calcium, collagen, glucosamine, chondroitin, magnesium and vitamin K and D. They are added to soft gel, pill, powder and liquid-based pharmaceuticals, nutraceuticals and dietary supplements to improve the structural matrix of the bones and minimize the risks of fractures. They also aid in enhancing the strength and flexibility of the joints in the body to prevent arthritis and other temporary or chronic joint disorders.
Bone and Joint Health Ingredients Market Trends:
The increasing prevalence of orthopedic disorders, such as rheumatoid arthritis, tennis elbow and ligament injuries, is one of the key factors driving the growth of the market. Moreover, rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. With the increasing health consciousness, there is a rising acceptance for dietary and nutritional supplements among the masses. Athletes and fitness enthusiasts are also widely adopting bone and joint health and sports supplements to prevent nutritional deficiencies, joint deterioration and subsequent injuries in the body. Additionally, various product innovations, such as the launch of natural and organically sourced bone and joint health ingredients that cater to the requirements of the vegan population, are contributing to the growth of the market. Other factors, including significant growth in the pharmaceutical industry, along with rising healthcare expenditure capacities of the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone and joint health ingredients market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on form, type, distribution channel, application and end user.
Breakup by Form:
- Soft Gels/Pills
- Powder
- Liquid
Breakup by Type:
- Vitamins
- Calcium
- Collagen
- Glucosamine
- Omega-3
- Magnesium
- Others
Breakup by Distribution Channel:
- Pharmacies and Drug Stores
- Health and Beauty Stores
- Specialty Stores
- Online Stores
- Others
Breakup by Application:
- Dietary Supplements
- Functional Foods and Beverages
- Others
Breakup by End User:
- Men
- Women
- Senior Citizen
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amway Corp. (Alticor Inc.), Bioiberica S.A.U, Glanbia PLC, Herbalife Nutrition Ltd., Innophos Holdings Inc., Kappa Bioscience, Koninklijke DSM NV, NOW Foods, NutriGold Inc., Rousselot Inc. (Darling Ingredients), Waitaki Bio and William Reed Group Ltd.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Segment Coverage |
Form, Type, Distribution Channel, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Amway Corp. (Alticor Inc.), Bioiberica S.A.U, Glanbia PLC, Herbalife Nutrition Ltd., Innophos Holdings Inc., Kappa Bioscience, Koninklijke DSM NV, NOW Foods, NutriGold Inc., Rousselot Inc. (Darling Ingredients), Waitaki Bio and William Reed Group Ltd. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global bone and joint health ingredients market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global bone and joint health ingredients market?
- What are the key regional markets?
- What is the breakup of the market based on the form?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the distribution channel?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global bone and joint health ingredients market and who are the key players?
- What is the degree of competition in the industry?